SGLT2 inhibitor is kidney protective, even if eGFR <30
This video was recorded in response to a recent publication in CJASN by George Bakris and colleagues.
George L. Bakris, Professor of Medicine and Director of Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL, USA.
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.